Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Forum
  • Discovery
  • About Us
    • Our Coverage
    • Team

Vivesto

0.08 SEK

+4.34 %

Less than 1K followers

VIVE

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Vivesto

2019202020212022202320242025
Revenue2.0201.826.21.0
growth-%10,094.1 %-87.0 %-96.1 %
EBITDA-113.5-10.1-99.8-90.5-74.8-27.4-32.6
EBIT-120.1-30.7-128.6-165.0-132.2-42.0-34.4
Profit before taxes-138.2-43.9-132.7-166.7-128.7-39.8-34.1
Net income-171.0-11.1-132.7-166.7-128.7-39.8-34.1
EPS-0.55-0.02-0.26-0.30-0.21-0.06-0.05
Dividend0.000.000.000.000.000.000.00
Dividend ratio-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%-5,734.6 %-5.0 %-380.9 %-8,875.5 %
EBIT-%-6,067.3 %-15.2 %-491.2 %-16,177.5 %
ROE-40.3 %-1.3 %-24.1 %-32.3 %-65.1 %-25.1 %-27.4 %
ROI-26.5 %-1.1 %-22.3 %-30.5 %-58.3 %-23.0 %-22.9 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.